Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medizone International, Inc. MZEI


Primary Symbol: MZEIQ

Medizone International Inc is the business of disinfection. The firm's primary focus is hospital disinfection. Its main product is AsepticSure. It is an ozone-based disinfectant formula used for disinfection of surfaces in hospitals, clinics, hotels, sporting venues and also in the food industry and long-term care facilities and other infrastructures.


PINL:MZEIQ - Post by User

Post by threwerbackon Jun 28, 2010 12:16pm
239 Views
Post# 17227481

Shareholder Update from the Chairman June 28, 2010

Shareholder Update from the Chairman June 28, 2010

Shareholder Update from the Chairman

June 28, 2010

Dear Shareholders,

In response to numerous requests for a progress report regarding our AsepticSure™ beta testing program, I wish to advise all interested parties that negotiations are well underway with a well known Ontario hospital. Our prototype decontamination system is fully prepared for deployment and subject to a final review for health and safety, full approval to begin beta-testing is soon expected without further delay.

While this review process by the Hospital Health and Safety Committee has taken longer than originally anticipated, this is a standard requirement when new devices are being introduced into a hospital environment. The hospital’s CEO and VP Medical Services have already approved the proposal using words such as “astonishing” and “imperative” to describe the technology.

In other on-going developments, the entire scientific and patent team have been working diligently for weeks now on preparation of a patent filing under the International Patent Cooperation Treaty (PCT). The filing will include both US patent application 61/223,219 titled “Healthcare Facility Disinfecting System” and US patent application 61/295,851 titled “Disinfecting Process and Apparatus.” As of January 14, 2010 142 member states had signed the PCT. A complete list of member countries may be sourced at, www.wipo.int/pct/guide/en/gdvol1/annexes/annexa/ax_a.pdf

Following recent International meetings being held in Canada, at one of which our Dr Michael Shannon made a presentation on the science behind AsepticSure™, the company can assure shareholders that our technology and the science behind it have now been brought into awareness at very high levels of government. Due to the sensitivity of some of the subject matter, shareholders should not expect any further information to be forthcoming for some time in this area.

I hope shareholders understand that progress is being made on many fronts. As specific milestones are met, we will announce them whenever possible.

Yours truly,

Ed

Edwin G. Marshall
Chairman of the Board
Chief Executive Officer

Bullboard Posts